Quality of life (ovarian cancer risk perception): BRCA1 only
1 finding from 1 review
Overall survival: RRSO alone vs RRSO and RRM
1 finding from 1 review
Overall survival: RRSO and RRM vs no RRSO
It is very uncertain whether risk‐reducing salpingo‐oophorectomy (RRSO) changes overall survival: RRSO and RRM vs no RRSO compared with no RRSO (very low certainty).
1 finding from 1 review
Breast Cancer‐related Death
2 findings from 1 review
Incidence of fractures
4 findings from 1 review
no estimate extracted
0 studies · 0 participants
GRADE not reported
no estimate extracted
0 studies · 0 participants
GRADE not reported
no estimate extracted
0 studies · 0 participants
GRADE not reported
Show 1 more finding
HGSC mortality: BRCA1 or BRCA2
It is very uncertain whether risk‐reducing salpingo‐oophorectomy (RRSO) changes HGSC mortality: BRCA1 or BRCA2 compared with no RRSO (very low certainty).
1 finding from 1 review
Severe adverse events
4 findings from 1 review
no estimate extracted
0 studies · 0 participants
GRADE not reported
no estimate extracted
0 studies · 0 participants
GRADE not reported
no estimate extracted
0 studies · 0 participants
GRADE not reported
Show 1 more finding
Overall survival
2 findings from 1 review
HGSC mortality
2 findings from 1 review
Breast cancer mortality: ≤ 50 years
It is very uncertain whether risk‐reducing salpingo‐oophorectomy (RRSO) changes breast cancer mortality: ≤ 50 years compared with no RRSO (very low certainty).
2 findings from 1 review
Breast cancer mortality: > 50 years
It is very uncertain whether risk‐reducing salpingo‐oophorectomy (RRSO) changes breast cancer mortality: > 50 years compared with no RRSO (very low certainty).
2 findings from 1 review
Breast cancer mortality: BRCA1 or BRCA
It is very uncertain whether risk‐reducing salpingo‐oophorectomy (RRSO) changes breast cancer mortality: BRCA1 or BRCA compared with no RRSO (very low certainty).
1 finding from 1 review
Quality of life (ovarian cancer risk perception): BRCA1 or BRCA2
1 finding from 1 review
Quality of life (breast cancer risk perception): BRCA1 or BRCA2
1 finding from 1 review
Overall survival: BRCA1 only
It is very uncertain whether risk‐reducing salpingo‐oophorectomy (RRSO) changes overall survival: BRCA1 only compared with no RRSO according to BRCA mutation status (very low certainty).
1 finding from 1 review
Overall survival: BRCA2 only
It is very uncertain whether risk‐reducing salpingo‐oophorectomy (RRSO) changes overall survival: BRCA2 only compared with no RRSO according to BRCA mutation status (very low certainty).
1 finding from 1 review
Mean GI symptom scores · People with urological (prostate) and gynaecological (cervical) cancer
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Acute and late GI toxicity (grade 2+) · People with urological (prostate) and gynaecological (endometrial) cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Diarrhoea (grade 2+) · People undergoing RT for pelvic cancer
Summary of findings: Probiotics may leads to lower diarrhoea (grade 2+) compared with control (placebo or no intervention) (low certainty).
1 finding from 1 review
QoL · People undergoing RT for pelvic cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found